BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chiappini S, Guirguis A, John A, Corkery JM, Schifano F.  Front Psychiatry. 2020; COVID-19: The Hidden Impact on Mental Health and Drug Addiction. [PMID: 32848937 DOI: 10.3389/fpsyt.2020.00767] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 38.0] [Reference Citation Analysis]
Number Citing Articles
1 Di Trana A, Carlier J, Berretta P, Zaami S, Ricci G. Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances. Front Psychiatry 2020;11:584462. [PMID: 33192730 DOI: 10.3389/fpsyt.2020.584462] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
2 Oesterle TS, Kolla B, Risma CJ, Breitinger SA, Rakocevic DB, Loukianova LL, Hall-Flavin DK, Gentry MT, Rummans TA, Chauhan M, Gold MS. Substance Use Disorders and Telehealth in the COVID-19 Pandemic Era: A New Outlook. Mayo Clin Proc 2020;95:2709-18. [PMID: 33276843 DOI: 10.1016/j.mayocp.2020.10.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
3 Singh Balhara YP, Szerman N, Singh S, Martinez Raga J, Salom C, Peris L, Ganesh R. Treatment Needs and Service Delivery for Patients with Dual Disorders During the COVID-19 Pandemic: Findings From the WADD Survey. J Dual Diagn 2021;:1-9. [PMID: 34165030 DOI: 10.1080/15504263.2021.1940413] [Reference Citation Analysis]
4 Dittrich T, Polymeris A, De Marchis GM. Challenges of treatment adherence with direct oral anticoagulants in pandemic. Curr Opin Neurol 2021;34:38-44. [PMID: 33230038 DOI: 10.1097/WCO.0000000000000888] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wojciechowski T. Relevance of the dual systems model for predicting drug/alcohol dependence in early adulthood among previously adjudicated young adults. Drug Alcohol Depend 2021;226:108876. [PMID: 34225226 DOI: 10.1016/j.drugalcdep.2021.108876] [Reference Citation Analysis]
6 Muntaner C, Gunn V, Prins SJ. On Case and Deaton's deaths of despair: implications for health inequalities research in the post-COVID-19 era. Gac Sanit 2021;35:409-10. [PMID: 34247894 DOI: 10.1016/j.gaceta.2021.03.001] [Reference Citation Analysis]
7 Zoob Carter BN, Boardley ID, van de Ven K. The Impact of the COVID-19 Pandemic on Male Strength Athletes Who Use Non-prescribed Anabolic-Androgenic Steroids. Front Psychiatry 2021;12:636706. [PMID: 33828494 DOI: 10.3389/fpsyt.2021.636706] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Fidancı İ, Aksoy H, Yengil Taci D, Ayhan Başer D, Cankurtaran M. Evaluation of the effect of the Covid-19 pandemic on smoking addiction levels. Int J Clin Pract 2021;75:e14012. [PMID: 33411384 DOI: 10.1111/ijcp.14012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Catalani V, Corkery JM, Guirguis A, Napoletano F, Arillotta D, Zangani C, Vento A, Schifano F. Psychonauts' psychedelics: A systematic, multilingual, web-crawling exercise. Eur Neuropsychopharmacol 2021;49:69-92. [PMID: 33857740 DOI: 10.1016/j.euroneuro.2021.03.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Janulis P, Newcomb ME, Mustanski B. Decrease in prevalence but increase in frequency of non-marijuana drug use following the onset of the COVID-19 pandemic in a large cohort of young men who have sex with men and young transgender women. Drug Alcohol Depend 2021;223:108701. [PMID: 33865210 DOI: 10.1016/j.drugalcdep.2021.108701] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Ganesan B, Al-Jumaily A, Fong KNK, Prasad P, Meena SK, Tong RK. Impact of Coronavirus Disease 2019 (COVID-19) Outbreak Quarantine, Isolation, and Lockdown Policies on Mental Health and Suicide. Front Psychiatry 2021;12:565190. [PMID: 33935817 DOI: 10.3389/fpsyt.2021.565190] [Reference Citation Analysis]
12 Schifano F, Chiappini S, Corkery JM, Scherbaum N, Guirguis A. The e-psychonaut drugs' psychopharmacology. Curr Opin Pharmacol 2021;57:165-74. [PMID: 33774473 DOI: 10.1016/j.coph.2021.02.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Schifano F, Chiappini S, Miuli A, Mosca A, Santovito MC, Corkery JM, Guirguis A, Pettorruso M, Di Giannantonio M, Martinotti G. Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants. Front Psychiatry 2021;12:657397. [PMID: 34025478 DOI: 10.3389/fpsyt.2021.657397] [Reference Citation Analysis]
14 Mougharbel F, Sampasa-Kanyinga H, Heidinger B, Corace K, Hamilton HA, Goldfield GS. Psychological and Demographic Determinants of Substance Use and Mental Health During the COVID-19 Pandemic. Front Public Health 2021;9:680028. [PMID: 34249844 DOI: 10.3389/fpubh.2021.680028] [Reference Citation Analysis]
15 Roe L, Proudfoot J, Tay Wee Teck J, Irvine RDG, Frankland S, Baldacchino AM. Isolation, Solitude and Social Distancing for People Who Use Drugs: An Ethnographic Perspective. Front Psychiatry 2020;11:623032. [PMID: 33519561 DOI: 10.3389/fpsyt.2020.623032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Catalani V, Arillotta D, Corkery JM, Guirguis A, Vento A, Schifano F. Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach. Front Psychiatry 2020;11:632405. [PMID: 33633599 DOI: 10.3389/fpsyt.2020.632405] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
17 Kilian C, Rehm J, Allebeck P, Braddick F, Gual A, Barták M, Bloomfield K, Gil A, Neufeld M, O'Donnell A, Petruželka B, Rogalewicz V, Schulte B, Manthey J; European Study Group on Alcohol Use and COVID-19. Alcohol consumption during the COVID-19 pandemic in Europe: a large-scale cross-sectional study in 21 countries. Addiction 2021. [PMID: 34109685 DOI: 10.1111/add.15530] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Scherbaum N, Bonnet U, Hafermann H, Schifano F, Bender S, Grigoleit T, Kuhn J, Nyhuis P, Preuss UW, Reymann G, Schneider U, Shibata J, Specka M. Availability of Illegal Drugs During the COVID-19 Pandemic in Western Germany. Front Psychiatry 2021;12:648273. [PMID: 33967857 DOI: 10.3389/fpsyt.2021.648273] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Kesten JM, Holland A, Linton MJ, Family H, Scott J, Horwood J, Hickman M, Telfer M, Ayres R, Hussey D, Wilkinson J, Hines LA. Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): A qualitative study of experiences of COVID-19 among people who inject drugs. Int J Drug Policy 2021;98:103391. [PMID: 34343945 DOI: 10.1016/j.drugpo.2021.103391] [Reference Citation Analysis]
20 Stowe MJ, Calvey T, Scheibein F, Arya S, Saad NA, Shirasaka T, Dannatt L, Ghosh A, Yee A, Ratta-Apha W, Vadivel R, Siste K, Shah B, Ramalho R, Narasimha VL, Delic M, Peyron E, Onoria JLG, Pant SB, Boujraf S, Grandinetti P, Morgan N. Access to Healthcare and Harm Reduction Services During the COVID-19 Pandemic for People Who Use Drugs. J Addict Med 2020;14:e287-9. [PMID: 33009167 DOI: 10.1097/ADM.0000000000000753] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
21 Wilkinson R, Hines L, Holland A, Mandal S, Phipps E. Rapid evidence review of harm reduction interventions and messaging for people who inject drugs during pandemic events: implications for the ongoing COVID-19 response. Harm Reduct J 2020;17:95. [PMID: 33261636 DOI: 10.1186/s12954-020-00445-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
22 Behera C, Gupta SK, Singh S, Balhara YPS. Trends in deaths attributable to suicide during COVID-19 pandemic and its association with alcohol use and mental disorders: Findings from autopsies conducted in two districts of India. Asian J Psychiatr 2021;58:102597. [PMID: 33631537 DOI: 10.1016/j.ajp.2021.102597] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
23 Cai CZ, Lin YL, Hu ZJ, Wong LP. Psychological and mental health impacts of COVID-19 pandemic on healthcare workers in China: A review. World J Psychiatry 2021;11:337-46. [PMID: 34327126 DOI: 10.5498/wjp.v11.i7.337] [Reference Citation Analysis]
24 Moreta-Herrera R, López-Calle C, Caycho-Rodríguez T, Cabezas Guerra C, Gallegos M, Cervigni M, Martino P, Barés I, Calandra M. Is it possible to find a bifactor structure in the Fear of COVID-19 Scale (FCV-19S)? Psychometric evidence in an Ecuadorian sample. Death Stud 2021;:1-11. [PMID: 33945438 DOI: 10.1080/07481187.2021.1914240] [Reference Citation Analysis]
25 Shreffler J, Shreffler M, Murfree JR, Huecker M. A Global Pandemic and Substance Use Disorder: Healthcare Professionals' Viewpoints on the Merging of Two Crises. Subst Use Misuse 2021;56:1476-82. [PMID: 34130597 DOI: 10.1080/10826084.2021.1936052] [Reference Citation Analysis]
26 Jing GP, Katz CL. An update on psychotic spectrum disorders and disasters. Curr Opin Psychiatry 2021;34:211-5. [PMID: 33605621 DOI: 10.1097/YCO.0000000000000700] [Reference Citation Analysis]
27 Mariottini C, Ojanperä I, Kriikku P. Increase in drugs-of-abuse findings in post-mortem toxicology due to COVID-19 restrictions-First observations in Finland. Drug Test Anal 2021;13:867-70. [PMID: 33217177 DOI: 10.1002/dta.2982] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
28 d'Arqom A, Sawitri B, Nasution Z, Lazuardi R. "Anti-COVID-19" Medications, Supplements, and Mental Health Status in Indonesian Mothers with School-Age Children. Int J Womens Health 2021;13:699-709. [PMID: 34285594 DOI: 10.2147/IJWH.S316417] [Reference Citation Analysis]
29 Krausz RM, Wong JSH, Westenberg JN, Choi F, Schütz CG, Jang KL. Canada's Response to the Dual Public Health Crises: A Cautionary Tale. Can J Psychiatry 2021;66:349-53. [PMID: 33567889 DOI: 10.1177/0706743721993634] [Reference Citation Analysis]
30 Chiappini S, Schifano F, Martinotti G. Editorial: Prescribing Psychotropics: Misuse, Abuse, Dependence, Withdrawal and Addiction. Front Psychiatry 2021;12:688434. [PMID: 33995156 DOI: 10.3389/fpsyt.2021.688434] [Reference Citation Analysis]